Page last updated: 2024-09-03

modipafant and Cerebromeningitis

modipafant has been researched along with Cerebromeningitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Campos, MA; de Miranda, AS; Kroon, EG; Lacerda-Queiroz, N; Lima, GK; Pedroso, VS; Rachid, MA; Rodrigues, DH; Teixeira, AL; Teixeira, MM; Vilela, MC	1

Other Studies

1 other study(ies) available for modipafant and Cerebromeningitis

Article	Year
Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2016, Volume: 11, Issue:4 Topics: Animals; Brain; Dihydropyridines; Herpes Simplex; Herpesvirus 1, Human; Imidazoles; Male; Meningoencephalitis; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Severity of Illness Index	2016

Article

Year

Platelet Activating Factor (PAF) Receptor Deletion or Antagonism Attenuates Severe HSV-1 Meningoencephalitis.

Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2016, Volume: 11, Issue:4

Topics: Animals; Brain; Dihydropyridines; Herpes Simplex; Herpesvirus 1, Human; Imidazoles; Male; Meningoencephalitis; Mice; Mice, Inbred C57BL; Mice, Knockout; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Severity of Illness Index

2016